trapoxin a has been researched along with staurosporine in 1 studies
| Studies (trapoxin a) | Trials (trapoxin a) | Recent Studies (post-2010) (trapoxin a) | Studies (staurosporine) | Trials (staurosporine) | Recent Studies (post-2010) (staurosporine) |
|---|---|---|---|---|---|
| 42 | 0 | 7 | 6,272 | 58 | 976 |
| Protein | Taxonomy | trapoxin a (IC50) | staurosporine (IC50) |
|---|---|---|---|
| Chain A, Ribosomal protein S6 kinase alpha-1 | Homo sapiens (human) | 0.0003 | |
| Chain X, Tyrosine-protein kinase Lyn | Homo sapiens (human) | 0.0013 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chamberlin, H; Cohen, D; Fischer, DD; Kwon, PO; Sambucetti, LC; Trogani, N; Xu, H; Zabludoff, S | 1 |
1 other study(ies) available for trapoxin a and staurosporine
| Article | Year |
|---|---|
Histone deacetylase inhibition selectively alters the activity and expression of cell cycle proteins leading to specific chromatin acetylation and antiproliferative effects.
Topics: Acetylation; Anti-Bacterial Agents; CDC2 Protein Kinase; Cell Cycle; Chromatin; Cyclin E; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flow Cytometry; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; Immunoblotting; Microscopy, Fluorescence; Peptides; Phosphorylation; Precipitin Tests; Promoter Regions, Genetic; Retinoblastoma Protein; Staurosporine; Transfection; Tumor Cells, Cultured | 1999 |